Skip to main content

Press Release


The sale of 60% in MacGREGOR completed

Press Releases

The sale of 60% of the shares in the subsidiary MacGREGOR has been completed. Following approval by the competition authorities, the Industri Kapital investment fund has acquired a majority interest, 60% of the votes and capital, in a new company that includes MacGREGOR. The sale is at a price of SEK 900 M and results in a capital gain for Gambro of about SEK 400 M and releases about SEK 900 M in liquid funds. MacGREGOR is being deconsolidated in Gambro’s accounts as of July 1, 1998. Gambro will remain a 40% part-owner of the new company.

With the sale of the MacGREGOR subsidiary, the extensive restructuring and streamlining of the GroupÕs operations is completed. Since the start in 1991, some 60 subsidiaries and operations have been divested and major focus placed on medical technology. This has involved transactions totaling about SEK 90 billion.

Today, the Group is focused solely on medical technology/healthcare, with leading operations globally in four business areas:

Renal Care Products – Gambro Renal Products – is responsible for development, production, marketing and sales of dialysis products worldwide, and also renal care services in Europe and Asia. Total sales amount to approximately SEK 8 billion.

Renal Care Services – Gambro Healthcare – is reponsible for dialysis clinics operations in North and South America, in addition to marketing and sales of dialysis products in markets in North and South America. Total sales are approximately SEK 9 billion.

Cardiopulmonary Care – COBE CV – manufactures cardiovascular-surgery products, primarily for markets in North and South America, Europe and the Asia-Pacific region, with sales of approximately SEK 1 billion.

Blood Component Technology – COBE BCT – covers products for the separation and handling of blood components, with major markets in North and South America, Europe and the Asia-Pacific region and sales of approximately SEK 1 billion.


MacGREGOR is a global leading company in marine cargo handing. The company had sales in 1997 of SEK 3.6 billion, with 1,000 employees. Operations focus on cargo-handling systems for various types of ships, such as container, bulk, general cargo, RoRo, passenger and reefer vessels. The most important products are deck cranes, cargo hatches, RoRo ramps, container securing equipment, elevators and refrigeration plants. MacGREGOR has a strong base in Asia, including the partly owned subsidiary MacGREGOR-Kayaba. MacGREGOR has a total of more than 50 offices and service depots in over 25 countries.

Recent News

IK Partners to invest in BIOBank alongside Management and historical shareholders Verto Growth and Capital Croissance
Read More
IK Partners divests Yellow Hive to a newly established continuation fund
Read More
Stake in A-SAFE acquired by IK Partners
Read More